BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[U.S. trio wins Nobel Prize for Medicine; Merck to develop vaccine]]>http://www.bloggingstocks.com/2009/10/05/u-s-trio-wins-nobel-prize-for-medicine-merck-to-develop-vaccin/http://www.bloggingstocks.com/2009/10/05/u-s-trio-wins-nobel-prize-for-medicine-merck-to-develop-vaccin/http://www.bloggingstocks.com/2009/10/05/u-s-trio-wins-nobel-prize-for-medicine-merck-to-develop-vaccin/#commentsFiled under: ,

First, who are the Nobel Prize winners? Why is their research so important in the areas of aging and cancer detection?

Three Americans won the Nobel Prize for medicine. They are Elizabeth Balckburn, Jack Szostak and Carol Greider. Balckburn is with the University of California, San Francisco, Greider is with Johns Hopkins School of Medicine in Baltimore and Szostak is at the Harvard Medical School.


Continue reading U.S. trio wins Nobel Prize for Medicine; Merck to develop vaccine

U.S. trio wins Nobel Prize for Medicine; Merck to develop vaccine originally appeared on BloggingStocks on Mon, 05 Oct 2009 14:20:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments]]>agingcancergernGeronmedicineMerckmrkNobel PrizeNobelPrizevaccineMon, 05 Oct 2009 14:20:00 EST<![CDATA[Vical soars after winning U.S. patent for flu vaccines]]>http://www.bloggingstocks.com/2009/09/03/vical-soars-after-winning-u-s-patent-for-flu-vaccines/http://www.bloggingstocks.com/2009/09/03/vical-soars-after-winning-u-s-patent-for-flu-vaccines/http://www.bloggingstocks.com/2009/09/03/vical-soars-after-winning-u-s-patent-for-flu-vaccines/#commentsFiled under: ,

Vical Inc. (NASDAQ: VICL) surged higher out of the gate Thursday after scoring a U.S. patent for its pandemic and seasonal influenza vaccines, including those to shield against H1N1 (swine flu) and H5N1 (avian flu). Both treatments use Vical's patented Vaxfectin adjuvant, which helps to boost immunity.

While the H5N1 vaccine has completed early-stage human trials, the H1N1 vaccine has yet to be tested on human subjects. Positive results have been recorded from tests conducted on mice and rabbits, but VICL said earlier this year that it will require more funding to begin large-scale trials on humans.

Continue reading Vical soars after winning U.S. patent for flu vaccines

Vical soars after winning U.S. patent for flu vaccines originally appeared on BloggingStocks on Thu, 03 Sep 2009 12:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>avian fluH1N1H5N1influenzainthenewspandemicpatentshort sellersswine fluvaccineVical IncorporatedVICLThu, 03 Sep 2009 12:30:00 EST